Inhaled nitric oxide as a potential rescue therapy for persistent hepatopulmonary syndrome after liver transplantation.

Inhaled nitric oxide as a potential rescue therapy for persistent hepatopulmonary syndrome after liver transplantation. - PDF Download Free
2MB Sizes 2 Downloads 13 Views

Recommend Documents

The successful use of inhaled nitric oxide in the management of severe hepatopulmonary syndrome after orthotopic liver transplantation.
Hepatopulmonary syndrome (HPS) is characterized by pulmonary vasodilation and subsequent hypoxemia in the setting of hepatic dysfunction. There is currently no pharmacologic intervention that has been shown to significantly affect outcomes and liver

Acute right heart syndrome: Rescue treatment with inhaled nitric oxide.
Acute right heart syndrome is a common occurrence in intensive care units and is associated with a poor prognosis. There is lack of understanding of the involved pathophysiology, standard diagnostic protocols and treatment guidelines. Management goal

The effect of inhaled nitric oxide therapy on thromboelastogram in newborns with persistent pulmonary hypertension.
Studies about the effects of inhaled nitric oxide (iNO) on bleeding time and platelet aggregation in newborns are limited in number and have inconclusive results. Thromboelastogram (TEG) shows the combined effects of coagulation factors and platelet

Inhaled nitric oxide as adjunctive therapy for severe malaria: a randomized controlled trial.
Severe malaria remains a major cause of childhood mortality globally. Decreased endothelial nitric oxide is associated with severe and fatal malaria. The hypothesis was that adjunctive inhaled nitric oxide (iNO) would improve outcomes in African chil

Proposed management algorithm for severe hypoxemia after liver transplantation in the hepatopulmonary syndrome.
The hepatopulmonary syndrome (HPS) is defined as the triad of liver disease, intrapulmonary vascular dilatation, and abnormal gas exchange, and is found in 10-32% of patients with liver disease. Liver transplantation is the only known cure for HPS, b

Hepatopulmonary syndrome associated with nodular regenerative hyperplasia after liver transplantation in a child.
HPS is a significant complication of portal hypertension in children with chronic liver disease and is an established indication for LT. It is characterized clinically by the triad of pulmonary vascular dilatation causing hypoxemia in the setting of

Use of early inhaled nitric oxide therapy in fat embolism syndrome to prevent right heart failure.
Fat embolism syndrome (FES) is a life-threatening condition in which multiorgan dysfunction manifests 48-72 hours after long bone or pelvis fractures. Right ventricular (RV) failure, especially in the setting of pulmonary hypertension, is a frequent

Improved severe hepatopulmonary syndrome after liver transplantation in an adolescent with end-stage liver disease secondary to biliary atresia.
Hepatopulmonary syndrome (HPS) is a serious complication of end-stage liver disease, which is characterized by hypoxia, intrapulmonary vascular dilatation, and liver cirrhosis. Liver transplantation (LT) is the only curative treatment modality for pa